ERBB2 and breast carcinoma: published an article in Science titled “Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neu Oncogene.” This groundbreaking study first revealed that the amplification of the HER-2/neu oncogene was an important predictor of the overall survival and time to relapse for breast cancer patients.